These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 4612715

  • 1. [Value of a pharmaceutic preparation combining benziodarone with an alkalinizator for the treatment of gout].
    André LJ, Delprat J.
    Sem Hop Ther; 1974; 50(5-6):376-80. PubMed ID: 4612715
    [No Abstract] [Full Text] [Related]

  • 2. [A new medicine for gout ailments: benziodarone].
    Deshayes P, Cardinael Y.
    Rhumatologie; 1967; 19(7):255-8. PubMed ID: 5619724
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R, Pagnan A, Fedele D, Novello M, Crepaldi G.
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gout: its causes, symptoms and treatment.
    Hill J.
    Nurs Times; 1972; 95(47):48-50. PubMed ID: 11096905
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Uricosuric and anti-gout action of certain benzofuran derivatives].
    Delbarre F, Auscher C, Amor B.
    Presse Med (1893); 1965 Nov 13; 73(48):2725-6. PubMed ID: 5842108
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of hyperuricemia and gout].
    Gröbner W, Walter-Sack I.
    Med Monatsschr Pharm; 2005 May 13; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract] [Full Text] [Related]

  • 15. [The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].
    Lindusková M, Vykydal M.
    Cas Lek Cesk; 1990 Nov 30; 129(48):1524-5. PubMed ID: 2257602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F, Auscher C, Saporta L, de Grey A, Danchot J.
    Rev Rhum Mal Osteoartic; 1973 Apr 30; 40(4):275-7. PubMed ID: 4716906
    [No Abstract] [Full Text] [Related]

  • 19. [Benzodiarone in the therapy of gout].
    Chériè Lignière G, Solazzi F.
    Reumatismo; 1968 Apr 30; 20(1):53-62. PubMed ID: 5708869
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical and biological action of a new hypouricemiant (benziodarone) in gout. Results of 2 years of experience].
    Santamaría A, Barceló P.
    Rev Esp Reum Enferm Osteoartic; 1968 Oct 30; 12(8):252-63. PubMed ID: 4899417
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.